NASDAQ:DERM | Cash Flow Statement | Journey Medical Corp

Complete source-backed cash-flow history.

Available history
2020-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$312,000.00
2026-03-31-$2.23M$2.91M$220,000.00
2025-12-31-$1.25M-$6.28M$5.43M
2025-09-30-$2.32M
2025-06-30-$3.8M
2025-03-31-$4.07M-$2.83M$3.6M
2024-12-31$1.52M$2.23M$10.62M
2024-09-30-$2.39M
2024-06-30-$3.36M
2024-03-31-$10.44M-$5.02M$1.64M
2023-12-31-$2.14M-$16.52M$0.00$19.21M
2023-09-30$16.79M
2023-06-30-$8.36M
2023-03-31-$10.14M-$956,000.00-$5M$52,000.00
2022-12-31-$10.64M-$3.84M$0.00$948,000.00
2022-09-30-$10.08M
2022-06-30-$7.53M
2022-03-31-$1.38M$884,000.00-$20M$11.37M
2021-12-31-$21.75M-$3.21M-$1.2M$31.8M
2021-09-30-$10.65M
2021-06-30-$11.87M
2021-03-31$268,000.00$1.36M$9.39M
2020-12-31$2.5M$1,000.00$5.05M-$200,000.00
2020-09-30$29,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$11.43M-$12.44M$16.23M
2024-12-31-$14.67M-$9.13M-$15M$16.99M
2023-12-31-$3.85M$5.24M-$5M-$4.8M
2022-12-31-$29.63M-$13.53M-$20M$16.46M
2021-12-31-$43.99M$0.00-$2.18M-$10M$53.02M
2020-12-31$5.28M$5,000.00$5.13M-$1.2M-$487,000.00